Y. Ozaki et al., PROTEIN-KINASE-C INHIBITORS SUPPRESS DISC-SPHERE CHANGES OF HUMAN PLATELETS, AS ASSESSED WITH THE SHAPE-CHANGE PARAMETER, European journal of pharmacology, 235(2-3), 1993, pp. 255-265
Changes in the shape of human platelets and the biochemical mechanism
responsible were evaluated, using the shape-change parameter. Neither
the Na+/H+ exchanger, nor intracellular or extracellular calcium ions
(Ca2+) affected disc-sphere changes induced by low doses of thrombin.
Treatment with inhibitors of Ca2+ mobilization, calmodulin or mysoin l
ight-chain kinase had no significant effect on the shape change of pla
telets. Staurosporine and H-7, both of which are inhibitors of protein
kinase C, inhibited disc-sphere changes at low concentrations. Moreov
er, calphostin C, a specific inhibitor of protein kinase C, effectivel
y inhibited thrombin-induced shape change, as assessed by the shape-ch
ange parameter, in a dose-dependent manner. 1-oleoyl-2-acetyl-glycerol
and 1,2-dioctanoyl-glycerol, which are synthetic protein kinase C act
ivators, induced shape changes similar to those induced by thrombin. A
decrease in the surface area of platelet images on scanning electron
micrographs was used to quantify the disc-sphere transformation. The m
ean platelet areas was significantly decreased after stimulation with
thrombin or 1-oleoyl-2-acetyl-glycerol. Pretreatment with H-7 inhibite
d the thrombin-induced disc-sphere change, as assessed by changes in t
he platelet surface area. Our results obtained with various inhibitors
suggest that thrombin-induced platelet change, as assessed by the sha
pe-change parameter, are associated with activation of protein kinase
C.